Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20


Heparin use for diagnostic cardiac catheterization with a radial artery approach: An international survey of practice patterns.

Bossard M, Lavi S, Rao SV, Cohen DJ, Cantor WJ, Bainey KR, Valettas N, Jolly SS, Mehta SR.

Catheter Cardiovasc Interv. 2018 Feb 6. doi: 10.1002/ccd.27530. [Epub ahead of print]


Unconventional warfare: Successful ablation of ventricular tachycardia by direct ventricular puncture in a patient with double mechanical heart valves.

Menon SD, Whitlock R, Valettas N, Healey JS.

HeartRhythm Case Rep. 2017 Oct 16;3(12):599-603. doi: 10.1016/j.hrcr.2017.10.007. eCollection 2017 Dec. No abstract available.


Randomized Controlled Trial of Radiation Protection With a Patient Lead Shield and a Novel, Nonlead Surgical Cap for Operators Performing Coronary Angiography or Intervention.

Alazzoni A, Gordon CL, Syed J, Natarajan MK, Rokoss M, Schwalm JD, Mehta SR, Sheth T, Valettas N, Velianou J, Pandie S, Al Khdair D, Tsang M, Meeks B, Colbran K, Waller E, Fu Lee S, Marsden T, Jolly SS.

Circ Cardiovasc Interv. 2015 Aug;8(8):e002384. doi: 10.1161/CIRCINTERVENTIONS.115.002384.


Stroke in the TOTAL trial: a randomized trial of routine thrombectomy vs. percutaneous coronary intervention alone in ST elevation myocardial infarction.

Jolly SS, Cairns JA, Yusuf S, Meeks B, Gao P, Hart RG, Kedev S, Stankovic G, Moreno R, Horak D, Kassam S, Rokoss MJ, Leung RC, El-Omar M, Romppanen HO, Alazzoni A, Alak A, Fung A, Alexopoulos D, Schwalm JD, Valettas N, Džavík V; TOTAL Investigators.

Eur Heart J. 2015 Sep 14;36(35):2364-72. doi: 10.1093/eurheartj/ehv296. Epub 2015 Jun 29.


A noncompaction reaction.

Alazzoni A, Nair V, Valettas N, Salehian O.

Circulation. 2014 May 27;129(21):2171-8. doi: 10.1161/CIRCULATIONAHA.114.009693. No abstract available.


Procedural volume and outcomes with radial or femoral access for coronary angiography and intervention.

Jolly SS, Cairns J, Yusuf S, Niemela K, Steg PG, Worthley M, Ferrari E, Cantor WJ, Fung A, Valettas N, Rokoss M, Olivecrona GK, Widimsky P, Cheema AN, Gao P, Mehta SR; RIVAL Investigators.

J Am Coll Cardiol. 2014 Mar 18;63(10):954-63. doi: 10.1016/j.jacc.2013.10.052. Epub 2013 Nov 21.


Strategies for multivessel revascularization in patients with diabetes.

Farkouh ME, Domanski M, Sleeper LA, Siami FS, Dangas G, Mack M, Yang M, Cohen DJ, Rosenberg Y, Solomon SD, Desai AS, Gersh BJ, Magnuson EA, Lansky A, Boineau R, Weinberger J, Ramanathan K, Sousa JE, Rankin J, Bhargava B, Buse J, Hueb W, Smith CR, Muratov V, Bansilal S, King S 3rd, Bertrand M, Fuster V; FREEDOM Trial Investigators.

N Engl J Med. 2012 Dec 20;367(25):2375-84. doi: 10.1056/NEJMoa1211585. Epub 2012 Nov 4.


Radial artery access as a predictor of increased radiation exposure during a diagnostic cardiac catheterization procedure.

Mercuri M, Mehta S, Xie C, Valettas N, Velianou JL, Natarajan MK.

JACC Cardiovasc Interv. 2011 Mar;4(3):347-52. doi: 10.1016/j.jcin.2010.11.011.


Dose comparisons of clopidogrel and aspirin in acute coronary syndromes.

CURRENT-OASIS 7 Investigators, Mehta SR, Bassand JP, Chrolavicius S, Diaz R, Eikelboom JW, Fox KA, Granger CB, Jolly S, Joyner CD, Rupprecht HJ, Widimsky P, Afzal R, Pogue J, Yusuf S.

N Engl J Med. 2010 Sep 2;363(10):930-42. doi: 10.1056/NEJMoa0909475. Erratum in: N Engl J Med. 2010 Oct 14;363(16):1585.


Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial.

Mehta SR, Tanguay JF, Eikelboom JW, Jolly SS, Joyner CD, Granger CB, Faxon DP, Rupprecht HJ, Budaj A, Avezum A, Widimsky P, Steg PG, Bassand JP, Montalescot G, Macaya C, Di Pasquale G, Niemela K, Ajani AE, White HD, Chrolavicius S, Gao P, Fox KA, Yusuf S; CURRENT-OASIS 7 trial investigators.

Lancet. 2010 Oct 9;376(9748):1233-43. doi: 10.1016/S0140-6736(10)61088-4.


Effect of rosiglitazone on progression of coronary atherosclerosis in patients with type 2 diabetes mellitus and coronary artery disease: the assessment on the prevention of progression by rosiglitazone on atherosclerosis in diabetes patients with cardiovascular history trial.

Gerstein HC, Ratner RE, Cannon CP, Serruys PW, García-García HM, van Es GA, Kolatkar NS, Kravitz BG, Miller DM, Huang C, Fitzgerald PJ, Nesto RW; APPROACH Study Group.

Circulation. 2010 Mar 16;121(10):1176-87. doi: 10.1161/CIRCULATIONAHA.109.881003. Epub 2010 Mar 1.


Predictors of increased radiation dose during percutaneous coronary intervention.

Mercuri M, Xie C, Levy M, Valettas N, Natarajan MK.

Am J Cardiol. 2009 Nov 1;104(9):1241-4. doi: 10.1016/j.amjcard.2009.06.037.


Images in cardiovascular medicine. Fluoroscopy of acutely thrombosed aortic valve.

Ravandi A, Sun JC, Lamy A, Valettas N.

Circulation. 2008 Nov 25;118(22):e705. doi: 10.1161/CIRCULATIONAHA.108.786228. No abstract available.


Images in cardiology: giant left atrium.

Ahmad M, Valettas N.

Clin Cardiol. 2006 Apr;29(4):179. No abstract available.


Does clopidogrel provide additional benefit to aspirin and fibrinolytic therapy in patients after STEMI?

Valettas N.

Nat Clin Pract Cardiovasc Med. 2005 Oct;2(10):500-1. No abstract available.


The role of platelets and platelet inhibition in acute myocardial infarction.

Valettas N, Herrmann HC.

Coron Artery Dis. 2003 Aug;14(5):357-63. Review. No abstract available.


Alcohol septal ablation complicated by complete heart block and permanent pacemaker failure.

Valettas N, Rho R, Beshai J, Lloyd CT, Ross HM, Kocovic D, Herrmann HC.

Catheter Cardiovasc Interv. 2003 Feb;58(2):189-93.


Comparison of degree of platelet inhibition by abciximab versus tirofiban in patients with unstable angina pectoris and non-Q-wave myocardial infarction undergoing percutaneous coronary intervention.

Herrmann HC, Swierkosz TA, Kapoor S, Tardiff DC, DiBattiste PM, Hirshfeld JW, Klugherz BD, Kolansky DM, Magness K, Valettas N, Wilensky RL.

Am J Cardiol. 2002 Jun 1;89(11):1293-7. No abstract available.


IIb or not IIb: when, how, and which GP IIb/IIIa inhibitor?

Swierkosz TA, Valettas N, Herrmann HC.

Catheter Cardiovasc Interv. 2001 Apr;52(4):433-4. No abstract available.


Supplemental Content

Loading ...
Support Center